tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Eun Yang, 146 are a BUY (77.66%), 36 are a HOLD (19.15%), 6 are a SELL (3.19%).
Analyst Eun Yang, carries an average stock price target met ratio of 54.4% that have a potential upside of 34.2% achieved within 320 days. Previously, Eun Yang worked at JEFFERIES.
Eun Yang’s has documented 382 price targets and ratings displayed on 47 stocks. The coverage was on Healthcare, Basic Materials, Technology, Energy sectors.
Most recent stock forecast was given on UTHR, United Therapeutics at 01-Mar-2026.
Analyst best performing recommendations are on CNTA (CENTESSA PHARMACEUTICALS PLC ADR).
The best stock recommendation documented was for BBIO (BRIDGEBIO PHARMA) at 1/27/2021. The price target of $72 was fulfilled within 12 days with a profit of $16.53 (29.8%) receiving and performance score of 24.83.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 15-Feb-2023
$42
$-2.15 (-4.87%)
$42
3 years 8 months 6 days ago
(15-Feb-2023)
0/16 (0%)
$-2.18 (-4.93%)
Hold Since 11-Jan-2023
$42
$-2.15 (-4.87%)
$68
3 years 9 months 10 days ago
(11-Jan-2023)
0/3 (0%)
$-2.1 (-4.76%)
Hold Since 11-Jan-2023
$42
$-2.15 (-4.87%)
$82
3 years 9 months 10 days ago
(11-Jan-2023)
0/4 (0%)
$-2.1 (-4.76%)
Hold Since 11-Jan-2023
$55
3 years 9 months 10 days ago
(11-Jan-2023)
0/1 (0%)
$36.77 (201.70%)
Buy Since 09-Jan-2023
$42
$-2.15 (-4.87%)
$61
3 years 9 months 12 days ago
(09-Jan-2023)
0/2 (0%)
$-1.85 (-4.22%)
